1
|
Seatla KK, Maruapula D, Choga WT, Ntsipe T, Mathiba N, Mogwele M, Kapanda M, Nkomo B, Ramaabya D, Makhema J, Mmalane M, Mine M, Kasvosve I, Lockman S, Moyo S, Gaseitsiwe S. HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana. Viruses 2021; 13:v13040594. [PMID: 33807382 PMCID: PMC8066386 DOI: 10.3390/v13040594] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 03/22/2021] [Accepted: 03/28/2021] [Indexed: 11/16/2022] Open
Abstract
There are limited real-world mutational and virological outcomes data of treatment-experienced persons diagnosed with HIV-1 subtype C (HIV-1 C) who are failing Integrase Strand Transfer Inhibitor-based regimens. Requisition forms sent for HIV-1 genotypic resistance testing (GRT) between May 2015 and September 2019 were reviewed and participants experiencing virologic failure while on dolutegravir (DTG) or raltegravir (RAL) cART at sampling recruited. Sanger sequencing of the HIV-1 Pol gene was performed from residual plasma samples and drug resistance mutational (DRM) analysis performed using the Stanford University HIV drug resistance database. 40 HIV-1C integrase sequences were generated from 34 individuals, 24 of whom were on DTG cART, three on RAL cART and seven on an unknown (DTG or RAL)-anchored cART at time of GRT. 11/34 (32%) individuals had DRMs to DTG and other integrase inhibitors. 7/11 (64%) patients had exposure to a RAL-based cART at the time of sampling. Out of the 11 individuals with DRMs, one (9%) had 2-class, 6 (55%) had 3-class, and 4 (36%) had 4-class multidrug-resistant HIV-1C. 7/11 individuals (64%) are currently virologically suppressed. Of the four individuals not virologically suppressed, three had extensive DRMs involving 4-classes of ARV drugs and one individual has demised. Resistance to DTG occurs more often in patients exposed to RAL cART. Individuals with 4-class DRMs plus integrase T97 and E157Q mutations appear to have worse outcomes. There is a need for frequent VL monitoring and GRT amongst treatment-experienced HIV-1C diagnosed individuals.
Collapse
Affiliation(s)
- Kaelo K. Seatla
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone 0000, Botswana;
- Correspondence: ; Tel.: +267-390-2671; Fax: +267-390-1284
| | - Dorcas Maruapula
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone 0000, Botswana;
| | - Wonderful T. Choga
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa
| | - Tshenolo Ntsipe
- National Health Laboratory, Ministry of Health & Wellness, Gaborone 0000, Botswana; (T.N.); (M.M.)
| | - Nametso Mathiba
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
| | - Mompati Mogwele
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
| | - Max Kapanda
- Botswana Ministry of Health and Wellness, Gaborone 0000, Botswana; (M.K.); (B.N.); (D.R.)
| | - Bornapate Nkomo
- Botswana Ministry of Health and Wellness, Gaborone 0000, Botswana; (M.K.); (B.N.); (D.R.)
| | - Dinah Ramaabya
- Botswana Ministry of Health and Wellness, Gaborone 0000, Botswana; (M.K.); (B.N.); (D.R.)
| | - Joseph Makhema
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
| | - Mompati Mmalane
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
| | - Madisa Mine
- National Health Laboratory, Ministry of Health & Wellness, Gaborone 0000, Botswana; (T.N.); (M.M.)
| | - Ishmael Kasvosve
- School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone 0000, Botswana;
| | - Shahin Lockman
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
- Department of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - Sikhulile Moyo
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- Department of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - Simani Gaseitsiwe
- Botswana Harvard AIDS Institute Partnership, Gaborone 0000, Botswana; (D.M.); (W.T.C.); (N.M.); (M.M.); (J.M.); (M.M.); (S.L.); (S.M.); (S.G.)
- Department of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| |
Collapse
|
2
|
Abstract
In Botswana, unplanned pregnancies, especially among the youth constitutes a growing health and social problem. Research in the field of contraceptive practices, and the causes of sexual practices in Botswana, remains scarce and relatively limited. The objectives of this study was to investigate the awareness and utilization of various contraceptive methods, among university students in Botswana. A descriptive, cross-sectional, research study was conducted among 346 randomly selected students, who completed confidential, self-administered questionnaires. The average age of the respondents was 21 years (SD = 2.8 years). The level of awareness among students regarding contraception was good (score ≥9). Both the male and the female students had almost similar awareness level of contraceptive use, as their mean scores were 8.79 and 8.72, respectively (p = .733). All the female students (100%) were ‘aware’ that the effectiveness of the contraceptives used, as compared to male students, being 93.7%. A greater proportion of the female students (90.6%) knew that using contraceptives irregularly would result in pregnancy, in contrast to 76.4% males. More than half (59.0%) of the students indicated that they had engaged in sexual acts. Significantly, more male students (68.5%) had sexual experiences prior to the study, compared to 54.5% of their female counterparts (p = .038). The majority of the students (76%) reported that they had always used contraceptive methods. The most commonly used contraceptive method was the condom (95.6%), followed by oral contraceptive pill (86.7%). There was no significant association found between the level of awareness and the use of contraceptives. Results suggested that many students still engaged in risky, contraceptive practices by engaging in unprotected sexual acts. Therefore, there is a need to educate the students about sexually transmitted infections, the different contraceptive methods and the regular use of the available contraceptives.
Collapse
Affiliation(s)
- M E Hoque
- a MSc, is affiliated to Graduate School of Business and Leadership at the University of KwaZulu-Natal , Westville Campus, South Africa
| | | | | |
Collapse
|